Genmab Takes Full Control of Acasunlimab Development Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/1/2026

1. AMZN
2. RBLX
3. AAPL
4. RDDT
5. COIN
6. NBIX
7. DXCM
8. GH
9. GDDY
10. WU

Go back to Genmab Takes Full Control of Acasunlimab Development Program
(NASDAQ: GMAB) Delayed: 28.87 +0.23 (0.80%)
Previous Close $28.64    52 Week High $ 
Open $28.51    52 Week Low $ 
Day High $28.93    P/E N/A 
Day Low $28.23    EPS $ 
Volume 2,135,229